
Trizin0.24%
Navana Pharmaceuticals Ltd.
Cetirizine Hydrochloride [Ophthalmic] is an ophthalmic (eye) antihistamine solution.
Cetirizine Hydrochloride [Ophthalmic] is an ophthalmic (eye) antihistamine solution. It is FDA-approved and established for a single, specific indication:
This ophthalmic formulation of Cetirizine Hydrochloride [Ophthalmic] is intended only for the eyes and is distinct from oral cetirizine tablets/syrups, which are used for systemic allergic conditions such as allergic rhinitis or urticaria. Cetirizine Hydrochloride [Ophthalmic] is not indicated for, and does not treat, infectious (bacterial or viral) conjunctivitis, dry eye disease, or glaucoma.
| Indication | Dose | Frequency |
|---|---|---|
| Ocular itching due to allergic conjunctivitis | Instill 1 drop in each affected eye | Twice daily, approximately 8 hours apart |
Cetirizine Hydrochloride [Ophthalmic] is generally well tolerated. The most commonly reported adverse reactions (occurring in approximately 1–7% of patients in clinical trials) include:
These effects are usually mild and transient. Patients should contact their physician if any reaction is severe, persistent, or accompanied by significant pain, discharge, or vision changes.
Cetirizine Hydrochloride [Ophthalmic] is contraindicated in patients with known hypersensitivity to cetirizine, hydroxyzine, or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.